Zacks Research Comments on Integer's Q2 Earnings (NYSE:ITGR)

Integer Holdings Co. (NYSE:ITGR - Free Report) - Research analysts at Zacks Research lifted their Q2 2026 earnings per share (EPS) estimates for Integer in a research report issued on Wednesday, May 28th. Zacks Research analyst R. Department now forecasts that the medical equipment provider will earn $1.69 per share for the quarter, up from their previous forecast of $1.62. The consensus estimate for Integer's current full-year earnings is $6.01 per share. Zacks Research also issued estimates for Integer's Q3 2026 earnings at $1.72 EPS, Q4 2026 earnings at $1.89 EPS, FY2026 earnings at $6.90 EPS, Q1 2027 earnings at $1.74 EPS and FY2027 earnings at $7.44 EPS.

ITGR has been the topic of several other reports. Truist Financial set a $150.00 price objective on shares of Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and increased their price target for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Raymond James increased their price target on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Benchmark reduced their target price on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Finally, Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $145.00.

Integer Price Performance

NYSE ITGR traded down $0.63 during trading on Friday, reaching $118.86. The company's stock had a trading volume of 377,531 shares, compared to its average volume of 374,440. The stock has a market capitalization of $4.15 billion, a PE ratio of 35.38, a P/E/G ratio of 1.72 and a beta of 1.03. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a fifty day moving average of $118.60 and a 200 day moving average of $128.63. Integer has a one year low of $104.93 and a one year high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last posted its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Integer's revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.14 EPS.

Insider Activity

In other news, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the sale, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. This trade represents a 87.82% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.16% of the company's stock.

Institutional Trading of Integer

Large investors have recently added to or reduced their stakes in the stock. KBC Group NV boosted its holdings in Integer by 83.3% in the fourth quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock valued at $212,000 after acquiring an additional 726 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of Integer by 3.9% during the fourth quarter. Principal Financial Group Inc. now owns 182,267 shares of the medical equipment provider's stock valued at $24,154,000 after buying an additional 6,905 shares during the period. Laurus Investment Counsel Inc. purchased a new position in shares of Integer during the fourth quarter valued at about $5,422,000. Congress Asset Management Co. boosted its position in Integer by 2.0% during the 4th quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider's stock valued at $66,041,000 after acquiring an additional 9,565 shares in the last quarter. Finally, Janney Montgomery Scott LLC boosted its position in Integer by 2.0% during the 4th quarter. Janney Montgomery Scott LLC now owns 9,865 shares of the medical equipment provider's stock valued at $1,307,000 after acquiring an additional 197 shares in the last quarter. Institutional investors own 99.29% of the company's stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.